Amy Daniel-Ulumben

Company: Compass Therapeutics

Job title: Senior Associate Scientist

Seminars:

Generation & Characterization of a Post-Checkpoint Inhibitor Mouse Tumor Model of Resistance 2:00 pm

Mouse models that mimic the patient population in the clinic who have acquired resistance to checkpoint therapies Combination efficacy of our clinical assets in the IO refractory tumor models Leveraging these findings to improve translation to benefit Post-CPI patientsRead more

day: Day 1 Track B PM